Autologous Polyclonal Tregs for Lupus

NCT02428309 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Stopped Due to participant recruitment feasibility

Conditions

Lupus Erythematosus, Cutaneous
Lupus Erythematosus, Discoid
Lupus Erythematosus, Systemic

Interventions

BIOLOGICAL: Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]